Gsk (GSK) Debt Ratio (2009 - 2026)
Gsk (GSK) posted quarterly Debt Ratio of 0.31 for Q2 2026, up 10.47% year-over-year from 0.28 in Q2 2025, and down 2.16% quarter-over-quarter from 0.31 in Q1 2026.
Gsk (GSK) Debt Ratio (2009 - 2026) Analysis & Trends
Gsk's Debt Ratio history runs 18 years deep, the most recent figure standing at 0.31 for Q2 2026.
- In Q2 2026, Debt Ratio rose 10.47% year-over-year to 0.31; the TTM figure through Jun 2026 stood at 0.31 (up 10.47% YoY), while the FY2025 annual figure was 0.33, down 215.67% from the prior year.
- Debt Ratio for Q2 2026 stood at 0.31, down from 0.31 in the prior quarter.
- The five-year high for Debt Ratio was 0.31 in Q4 2023, with the low at 0.43 in Q3 2022.
- The 5-year median for Debt Ratio is 0.33 (2024), against an average of 0.24.
- The sharpest annual moves came in 2023 and 2025: Debt Ratio surged 159.78% in 2023, then plunged 215.67% in 2025.
- Gsk's Debt Ratio stood at 0.12 in 2022, then soared by 159.78% to 0.31 in 2023, then slipped by 6.9% to 0.28 in 2024, then slumped by 215.67% to 0.33 in 2025, then gained by 4.66% to 0.31 in 2026.
- Business Quant data shows GSK's Debt Ratio at 0.31 in Q2 2026, 0.31 in Q1 2026, and 0.33 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.84 Bn | 633.08 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.10 Bn | 463.53 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 376.16 Bn | 369.02 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.94 Bn | 296.25 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.99 Bn | 253.09 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 236.45 Bn | 222.46 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 182.10 Bn | 178.92 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.60 Bn | 147.90 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.32 Bn | 102.15 Bn | 8.24 Bn | -0.31 |
| 10 | Sanofi | 55.17 Bn | 47.79 Bn | 10.79 Bn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.31 |
| Mar 31, 2026 | -0.31 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.35 |
| Mar 31, 2025 | -0.37 |
| Dec 31, 2024 | 0.28 |
| Sep 30, 2024 | -0.33 |
| Jun 30, 2024 | -0.34 |
| Mar 31, 2024 | -0.36 |
| Dec 31, 2023 | 0.31 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | -0.35 |
| Mar 31, 2023 | -0.38 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.27 |
| Mar 31, 2022 | -0.24 |
| Dec 31, 2021 | 0.11 |
| Sep 30, 2021 | -0.33 |